Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02572986 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies
A Phase 3 study of Scabies, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
- 13
- Study locations
NCT02572986: Completed Phase 3 study of Scabies, sponsored by Dr. Reddy's Laboratories Limited.
NCT02572986 is a Phase 3 study of Scabies that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 250 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (68% lower). The trial reports 13 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02572986, a Phase 3 study of Scabies, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
- 13
- Study locations
Study Summary
Scabies is an infestation of the skin by the human itch mite (Sarcoptes scabiei). Diagnosis of scabies is made based on clinical symptoms, such as nocturnal itching, and appearance and distribution of the rash. Definitive diagnosis includes the microscopic identification of the mite, mite eggs, or mite fecal matter in the skin. Topical permethrin is considered the drug of choice for the treatment of scabies. It is a synthetic pyrethroid that is safe for use in adults and children 2 months and older. This study will evaluate the therapeutic equivalence of a generic permethrin cream 5% to Elimite® in the Treatment of Scabies.
Conditions Studied
Interventions
- DRUG Permethrin
Study Locations (13)
Florida
- Solutions Through Advanced Research - Jacksonville
- San Marcus Research Clinic, Incorporation - Miami
- L & C Professional Medical Research Institute - Miami
- Vista Health Research, LLC - Miami
California
- Sun Rise Clinical Research, Inc - Bell Gardens
- Havana Research Institute - Pasadena
Other
- Clinica Dermatologica - San Salvador
- Clinica Dermatologica y Cirugia de Piel - Santa Tecla, La Libertad
Arizona
- Omni Dermatology - Phoenix
Pennsylvania
- Derm Dx Center for Dermatology - Hazleton
Texas
- Sun Research Institute - San Antonio
Washington
- Zain Research, LLC - Richland
PanamaCity
- Clinica Dermatologica Dra. Yariela Grajales - Panama City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-08 |
| Phase | Phase 3 |
What the finished NCT02572986 record still lists
NCT02572986 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Scabies appearing as the primary indexed condition, and to 1 intervention - of which Permethrin is the first listed.
NCT02572986 lists 13 locations in 8 states (Florida, California, Other).
Frequently Asked Questions
What is clinical trial NCT02572986 about?
NCT02572986 is a clinical study titled "A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies". Scabies is an infestation of the skin by the human itch mite (Sarcoptes scabiei). Diagnosis of scabies is made based on clinical symptoms, such as nocturnal itching, and appearance and distribution of the rash. Definitive diagnosis includes the microscopic identification of the mite, mite eggs, or m...
What is the current status of trial NCT02572986?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2015-09. Estimated completion is 2016-08.
What conditions does trial NCT02572986 study?
This clinical trial studies the following conditions: Scabies.
What interventions are being tested in trial NCT02572986?
The interventions under investigation include: Permethrin (DRUG).
Who is sponsoring clinical trial NCT02572986?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02572986 being conducted?
This trial has 13 study locations across Arizona, California, Florida, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Scabies
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02572986's enrollment target sits among peer trials
250 1249th of 2000 higher than 735 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies
COMPLETED · Phase 3
-
PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia